Stock · CVS · Healthcare
United States · Large Cap · listed since 1984 · Revenue 12 mo. $415.1B
Price as of 11/06/2026
CVS Health Corporation provides health solutions in the United States.
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Original text from the data provider
Summary
31.1 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €7B (2025), it supports €77.8B. The remaining €20.3B of the market value assume it grows 3.3% a year for 10 years and not at all afterwards.
Required FCF growth per year
3.3%
no growth afterwards
Price to operating cash flow 7.3×, within its usual range.
Middle half of 20 quarters: 6.4× to 9.3×, median 7.6×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q1 → Q2 2026
5 more unchanged: Revenue, 12 mo., Gross margin, EBIT margin, Net debt, Shares outstanding
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 2.35% | 11.52% | Rank 14 |
| Return on capital (Greenblatt) | 37.02% | 32.55% | Rank 58 |
| EBIT margin | 2.58% | 18.31% | Rank 10 |
| FCF margin | 1.94% | 14.12% | Rank 12 |
| Gross margin | 13.77% | 60.99% | Rank 6 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 7.85% | 8.04% | Rank 50 |
| Earnings growth, 3 years per year | −24.70% | 5.44% | Rank 8 |
| Earnings growth, 5 years per year | −23.94% | 7.00% | Rank 3 |
| Sustainable growth (ROE × retained earnings) | 0.70% | 3.66% | Rank 11 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 1.66% | 2.90% | Rank 20 |
| FCF yield | 7.14% | 3.63% | Rank 85 |
| EV/saleslower is better | 0.48 | 4.03 | Rank 91 |
| EV/EBITlower is better | 18.52 | 21.73 | Rank 63 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | −3.01% | 8.66% | Rank 37 |
| Share price, 6 months | −6.92% | 24.27% | Rank 6 |
| Share price, 3 months | −7.25% | 15.42% | Rank 5 |
| Distance from 52-week high | −24.19% | −7.35% | Rank 16 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −1.17% | 0.30% | Rank 63 |
| Change in share countlower is better | 0.71% | 0.00% | Rank 16 |
| Dividend streak in years | 28 | 10 | Rank 92 |
| Price reaction to results, market-adjusted | −5.03% | 0.05% | Rank 11 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 28.81% | 48.40% | Rank 19 |
| Net debt/EBITDAlower is better | 8.41 | 1.11 | Rank 1 |
| Debt to equitylower is better | 1.24 | 0.48 | Rank 15 |
| Volatility, 1 yearlower is better | 31.13% | 31.42% | Rank 54 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF, $B | Shares | Net debt, $B |
|---|---|---|---|---|---|
| 2016 | 177.5 | 5.9% | 7.9 | 1.08B | 24.2 |
| 2017 | 184.8 | 5.2% | 6.1 | 1.02B | 25.3 |
| 2018 | 194.6 | 2.1% | 6.8 | 1.04B | 69.4 |
| 2019 | 256.8 | 4.7% | 10.4 | 1.31B | 83.3 |
| 2020 | 268.7 | 5.2% | 13.4 | 1.31B | 77.2 |
| 2021 | 292.1 | 4.6% | 15.7 | 1.33B | 66.6 |
| 2022 | 322.5 | 2.5% | 13.5 | 1.32B | 57.8 |
| 2023 | 357.8 | 3.8% | 10.4 | 1.29B | 71.2 |
| 2024 | 372.8 | 2.3% | 6.3 | 1.26B | 74.3 |
| 2025 | 402.1 | 2.6% | 7.8 | 1.27B | 85.1 |
2 of 7 StockScorer Score rules met · How the score is built
CVS Health Corp mainly meets criteria in the Valuation category. Result from 18 strategies checked.
CVS Health Corp is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
2 of 7 rules met
4 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for CVS Health Corp.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 60.3 | 30.0 |
| P/B ratio | 1.4 | 4.8 |
| Return on equity (ROE) | 2.4% | 11.5% |
| Equity ratio | 28.8% | 48.4% |
| Debt-to-equity (D/E) | 1.24 | 0.48 |
| Dividend yield | 3.2% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| CVS | CVS Health Corpthis page | |
| ELV | Elevance Health Inc | Low3.6 |
| CI | The Cigna Group | Low4.5 |
| HUM | Humana Inc | Low2.7 |
| CNC | Centene Corp | locked |
| UNH | UnitedHealth Group Incorporated | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.